Pharmacokinetics: Peak plasma levels are reached after 30-60 min. Ectrin has subsequent complete metabolism in similar metabolites.
Treatment of acute bronchitis, chronic bronchitis and its exacerbations. Respiratory disorders characterized by abnormal bronchial secretions and impaired mucus transport.
Capsule: 1 cap 2-3 times daily.
Suspension: Adults and Children >30 kg: 10 mL (2 tsp) twice daily.
Children 20-30 kg: 5 mL (1 tsp) 3 times a day; 15-19 kg: 5 mL (1 tsp) twice daily.
Direction for Reconstitution: To make 60 mL suspension: Add 42 mL of water and shake well until all the powder are evenly suspended.
To make 100 mL suspension: Add 70 mL of water and shake well until all the powder are evenly suspended.
With dosages exceeding the recommended dose (1200 mg/day), sweating, vertigo and flushing have been observed.
Known hypersensitivity to erdosteine. Because of a possible interference of erdosteine metabolites with the methionine metabolism, erdosteine is contraindicated in patients suffering from hepatic cirrhosis and deficiency of the cystathionine-synthetase enzyme.
Suspension: Phenylketonuria, due to the presence of aspartame.
Effects on the Ability to Drive or Operate Machinery: No effects have been reported.
Use in pregnancy & lactation: The safety of erdosteine during human pregnancy has not been established and therefore, as with all other new drugs, its use is not recommended. Ectrin is also not recommended during lactation.
The safety of erdosteine during human pregnancy has not been established and therefore, as with all other new drugs, its use is not recommended. Ectrin is also not recommended during lactation.
No gastrointestinal nor systemic side effects due to Ectrin have been observed.
No harmful interactions have been observed with other medicaments and Ectrin can therefore be administered together with antibiotics and bronchodilators (theophylline or β2-mimetics and cough sedatives).
Store at a temperature not exceeding 30°C. Protect from light.
The reconstituted suspension is stable for 1 week (7 days) at temperatures not exceeding 30°C (room temperature) and 2 weeks (14 days) at 2-8°C temperature (refrigerated).
R05CB15 - erdosteine ; Belongs to the class of mucolytics. Used in the treatment of wet cough.
Ectrin cap 300 mg
100's;20's
Ectrin powd for oral susp 175 mg/5 mL
60 mL x 1's
Sign Out
Continue with Google
Sign up with email
Already a member?
Sign in
